NXCLF yields 1.97% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, NXCLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXCLF + JNJ for your $10,000?
LIFULL Co., Ltd. provides real estate information services in Japan. It offers LIFULL HOME'S, a site of real estate and housing information; LIFULL Revitalize Rural Japan that suggest new lifestyles to people in Japan based on refurbishment of abandoned houses; LIFULL Move that provides reviews and rankings of the moving companies; LIFULL Nursing Care, a special care facility searching web service; LIFULL Life Plan that provide the opportunity for updating life plan; LIFULL FLOWER, an online flower gift shop; and LIFULL Investment, a money funding website. The company also provides LIFULL FaM that enables working mothers balance childcare with work while pursuing a career; LIFULL rental spaces, a site for rental spaces and meeting rooms, event venues, and other rental facilities; LIFULL Storage, a storage space searching web service; LIFULL HUB, a shared office; LIFULL Fab to expand possibilities of design and craftsmanship; LIFULL Table, a mixed-style deli restaurant; and LIFULL Marketing Partners that offers full Web assistance for real estate related companies. In addition, it offers LivingAnywhere Commons, a community to live; instant house products; LIFULL Real Estate Crowdsourcing, an online advertising platform for property crowd funding projects; Trovit, an aggregation website; and Mitula, a site that provides information in real estate and housing, used cars, recruitment, and fashion. The company was formerly known as NEXT Co., Ltd. and changed its name to LIFULL Co., Ltd.in April 2017. LIFULL Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.
Full NXCLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.